Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drugs
4
×
fda
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer
eli lilly
investing
sarepta therapeutics
startups
abbvie
astrazeneca
bristol-myers squibb
cancer immunotherapy
celgene
What
bio
roundup
4
×
drug
fda
known
ahead
alzheimer’s
annual
approved
asco
assessed
attention
biopharma
biotech
branded
choices
commissioner
communities
companies
conference
congress
congressional
consumers
costly
counterweight
crispr
digital
disease
drugs
elevatebio
epidemic
esmo
europe
executives
fatty
feud
frenzied
generic
germany
graft
Language
Current search:
drugs
×
roundup
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More